Cargando…

A Patient with X-Linked Agammaglobulinemia and COVID-19 Infection Treated with Remdesivir and Convalescent Plasma

Detalles Bibliográficos
Autores principales:	Iaboni, Aled, Wong, Natalie, Betschel, Stephen D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2021
Materias:	Letter to Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7864799/ https://www.ncbi.nlm.nih.gov/pubmed/33547548 http://dx.doi.org/10.1007/s10875-021-00983-y

Ejemplares similares

Three patients with X-linked agammaglobulinemia hospitalized for COVID-19 improved with convalescent plasma
por: Jin, Haoli, et al.
Publicado: (2020)

Pharmacokinetics of convalescent plasma therapy in a COVID-19 patient with X-linked Agammaglobulinemia
por: Yates, Jennifer L., et al.
Publicado: (2022)

Monoclonal Antibodies for COVID-19 in X-linked Agammaglobulinemia: a Case Series
por: Simard, Marie-Lee, et al.
Publicado: (2023)

Impact of lanadelumab in hereditary angioedema: a case series of 12 patients in Canada
por: Iaboni, Aled, et al.
Publicado: (2021)

Longitudinal study of a SARS-CoV-2 infection in an immunocompromised patient with X-linked agammaglobulinemia
por: Ciuffreda, Laura, et al.
Publicado: (2021)

X-Linked Agammaglobulinemia Case with TH Domain Missense Mutation in Bruton Tyrosine Kinase
por: Agrebi, Nourhen, et al.
Publicado: (2021)

Rapid recovery of a SARS-CoV-2–infected X-linked agammaglobulinemia patient after infusion of COVID-19 convalescent plasma
por: Mira, Estefanía, et al.
Publicado: (2020)

Responses to SARS-CoV-2 Vaccines of Patients with Common Variable Immune Deficiencies and X-linked Agammaglobulinemia
por: Carrabba, Maria, et al.
Publicado: (2022)

Immunologic Control of Disseminated Aichi Virus Infection in X-Linked Agammaglobulinemia by Transplantation of TcRαβ-Depleted Haploidentical Hematopoietic Cells
por: Bekassy, Zivile, et al.
Publicado: (2022)

Splice-Correction Strategies for Treatment of X-Linked Agammaglobulinemia
por: Bestas, Burcu, et al.
Publicado: (2015)

Astrovirus Encephalitis in Boy with X-linked Agammaglobulinemia
por: Quan, Phenix-Lan, et al.
Publicado: (2010)

X-linked Agammaglobulinemia Presenting with Multiviral Pneumonia
por: Arroyo-Martinez, Yadis M, et al.
Publicado: (2020)

Autism in a Child With X-linked Agammaglobulinemia
por: Bied, Adam, et al.
Publicado: (2022)

Convalescent plasma to treat COVID-19: Its challenges in Iraq's situation
por: Hashim, H.T.
Publicado: (2020)

Second-dose mRNA COVID-19 vaccine safety in patients with immediate reactions after the first dose: A case series
por: Iaboni, Aled, et al.
Publicado: (2022)

SARS-CoV-2 Infection in an Adolescent With X-linked Agammaglobulinemia
por: Pereira, Noella Maria Delia, et al.
Publicado: (2021)

SARS-CoV-2 positive virus culture 7 weeks after onset of COVID-19 in an immunocompromised patient suffering from X chromosome-linked agammaglobulinemia
por: Guetl, Katharina, et al.
Publicado: (2021)

Early and persistent viral clearance in COVID-19 patients treated with convalescent plasma
por: Franchini, Massimo, et al.
Publicado: (2021)

Membranoproliferative Glomerulonephritis and X-Linked Agammaglobulinemia: An Uncommon Association
por: Lavrador, Vasco, et al.
Publicado: (2014)

Pyoderma Gangrenosum in a Patient with X-Linked Agammaglobulinemia
por: Tan, Qi, et al.
Publicado: (2017)

Agammaglobulinemia: from X-linked to Autosomal Forms of Disease
por: Cardenas-Morales, Melissa, et al.
Publicado: (2021)

Convalescent plasma for COVID-19 considerations
por: Adiwinata Pawitan, Jeanne
Publicado: (2021)

X-Linked Agammaglobulinemia: Infection Frequency and Infection-Related Mortality in the USIDNET Registry
por: O’Toole, Dana, et al.
Publicado: (2022)

In Reply—How Safe Is COVID-19 Convalescent Plasma?
por: Joyner, Michael J., et al.
Publicado: (2021)

Cytomegalovirus Pneumonia in a Patient with X-Linked Agammaglobulinemia: A Case Report
por: Wong, Yao-Xian, et al.
Publicado: (2022)

Convalescent plasma in the management of COVID-19 pneumonia
por: Elbadawi, Ayman, et al.
Publicado: (2021)

How Safe Is COVID-19 Convalescent Plasma?
por: Franchini, Massimo, et al.
Publicado: (2021)

COVID-19 convalescent plasma therapy and immunodeficiency
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2021)

Relapsing Campylobacter jejuni Systemic Infections in a Child with X-Linked Agammaglobulinemia
por: Ariganello, Paola, et al.
Publicado: (2013)

Convalescent plasma therapy for persistent hepatitis E virus infection
por: Ankcorn, Michael, et al.
Publicado: (2019)

Liver injury in remdesivir-treated COVID-19 patients
por: Zampino, Rosa, et al.
Publicado: (2020)

A Child with X-Linked Agammaglobulinemia and Enthesitis-Related Arthritis
por: Sukumaran, Sukesh, et al.
Publicado: (2011)

Clinical and mutational features of Vietnamese children with X-linked agammaglobulinemia
por: Vu, Quang Van, et al.
Publicado: (2014)

Tubulointerstitial nephritis complicating IVIG therapy for X-linked agammaglobulinemia
por: Sugimoto, Keisuke, et al.
Publicado: (2014)

Naïve Regulatory T Cell Subset Is Altered in X-Linked Agammaglobulinemia
por: Shelyakin, Pavel V., et al.
Publicado: (2021)

X-Linked Agammaglobulinemia Leading to Chronic Obstructive Lung Disease
por: Bean, Paris, et al.
Publicado: (2022)

A possible role for B cells in COVID-19? Lesson from patients with agammaglobulinemia
por: Quinti, Isabella, et al.
Publicado: (2020)

‘Treatment of COVID-19 with convalescent plasma’ – Author’s reply
por: Wooding, Denise J., et al.
Publicado: (2021)

Use of convalescent plasma in COVID-19 patients in China
por: Zhu, M., et al.
Publicado: (2020)

Convalescent plasma (CP) therapy in patients with COVID-19
por: Cakir, Banu
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ora6lcfs24q0kqmb41ov3k9bn2